Form 4: Datadog CEO Olivier Pomel Executes Stock Option and Sells Shares
SEC Form 4 Filing
Datadog's CEO, Olivier Pomel, exercised stock options and sold Class A Common Stock on April 1, 2024, according to a recent SEC filing.
Summary
- On April 1, 2024, Olivier Pomel, the CEO of Datadog, Inc., engaged in transactions involving the company's stock.
- Pomel exercised a stock option to acquire 150,240 shares of Class B Common Stock for $0.3067 per share.
- He then converted 85,637 shares of Class B Common Stock into Class A Common Stock.
- Pomel sold a total of 85,637 shares of Class A Common Stock in multiple transactions at weighted-average prices ranging from $122.2048 to $123.714 per share.
- These sales were executed under a pre-arranged 10b5-1 trading plan established on March 15, 2023.
- Following these transactions, Pomel directly owns 337,247 shares of Class A Common Stock and 8,717,126 shares of Class B Common Stock.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the transactions appear to be routine and pre-planned. The CEO is exercising options and selling shares, which is a normal part of executive compensation and financial planning.
Industry Context
Insider transactions are common, and the use of 10b5-1 plans allows insiders to sell shares over time while avoiding accusations of trading on non-public information. The market will likely interpret these sales in the context of Datadog's overall performance and future prospects.
Comparison to Industry Standards
- Comparing Pomel's transactions to other tech CEOs, the use of 10b5-1 plans is a standard practice.
- Companies like Microsoft, Amazon, and Google also see regular insider selling under similar plans.
- The size of the transactions is relatively small compared to the overall market capitalization of Datadog, suggesting it's more for personal financial management than a reflection of the CEO's view on the company's prospects.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the increased supply of shares in the market.
- However, the pre-planned nature of the sales should mitigate any significant negative perception.
Key Dates
| Date | Description |
|---|---|
| 03/15/2023 | Date of 10b5-1 plan |
| 04/01/2024 | Date of stock option exercise, conversion, and stock sales |
| 04/03/2024 | Date of Form 4 filing |
| 06/28/2029 | Expiration date of stock option |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.